BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
BioSig Technologies, Inc.Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time...
BioSig Technologies, Inc.Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time...